June 29, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
PHILADELPHIA — Medications that reduce blood pressure and improve glycemia may preserve kidney function over time despite initial eGFR dips, according to a speaker at the Heart in Diabetes CME Conference. Matthew R. Weir, MD, professor and chief in the division of nephrology at University of Maryland School of Medicine, said eGFR dips “should be expected and planned upon” when using
June 29, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Using a continuous glucose monitor improved time in range with no increase in hypoglycemia for people with type 2 diabetes…

PHILADELPHIA — With combination therapies and multiple treatment options available for patients, nephrology is in a “therapeutic…

Recent data reveal a striking paradox: While 73% of endocrinologists prescribe glucose-lowering medications, fewer than 10% of…

About 36 million U.S. adults have chronic kidney disease, with increasing prevalence tied to diabetes, according to study data…

PHILADELPHIA — Using a GLP-1 receptor agonist in combination with an SGLT2 inhibitor may provide additive cardiovascular and…

CHICAGO — In patients being treated for hypertension, those taking a GLP-1 receptor agonist had higher rates of hypotensive…